Katarzyna Radke

Anti‐tumor effects of <scp>PIM</scp> / <scp>PI</scp> 3K/ <scp>mTOR</scp> triple kinase inhibitor <scp>IBL</scp> ‐302 in neuroblastoma

Sofie Mohlin, Karin Hansson, Katarzyna Radke et al. · EMBO Molecular Medicine · 2019 · 44 citations · Full text

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance

Adriana Mañas, Kristina Aaltonen, Natalie Andersson et al. · Science Advances · 2022 · 42 citations · Full text

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

Karin Hansson, Katarzyna Radke, Kristina Aaltonen et al. · Science Translational Medicine · 2020 · 32 citations · Full text

Anti-tumor effects of rigosertib in high-risk neuroblastoma

Katarzyna Radke, Karin Hansson, Jonas Sjölund et al. · Translational Oncology · 2021 · 15 citations · Full text